Buradasınız

Anasayfa » Content

Banti’s syndrome in a young male

Journal Name:

  • Indian Journal of Basic & Applied Medical Research

Publication Year:

  • 2014

Key Words:

Author Name
Abstract (2. Language): 
Banti’s syndrome is a rare disease which is characterised by ascites, splenomegaly and portal hypertension without coexisting cirrhosis of liver. There is no geographical predilection for the disease. It is usually occurs around 3rd to 4th decade of life. Here we report a case of a 16 year old boy who presented with ascites, massive splenomegaly and pancytopenia. CECT abdomen revealed thrombosed portal radicals with normal liver. He was subsequently diagnosed to have Banti’s syndrome. Through this case we deduce that Banti’s syndrome must be considered in cases with portal hypertension though they may be of younger age group.
Bookmark/Search this post with
FULL TEXT (PDF): 
PDF icon arastirmax-bantis-syndrome-young-male.pdf
  • 1
134
138
  • English

REFERENCES

References: 

1. Sarin SK, Kumar A, Chawla YK, Baijal SS, Dhiman RK, Jafri W, et al. Noncirrhotic portal
fibrosis/idiopathic portal hypertension: APASL recommendations for diagnosis and treatment.
Hepatol Int. 2007 Sep;1(3):398–413.
2. Bhargava DK, Dasarathy S, Sundaram KR, Ahuja RK. Efficacy of endoscopic sclerotherapy on
long-term management of oesophageal varices: a comparative study of results in patients with
cirrhosis of the liver, non-cirrhotic portal fibrosis (NCPF) and extrahepatic portal venous
obstruction (EHO). J Gastroenterol Hepatol. 1991 Oct;6(5):471–5.
3. Dhiman RK, Chawla Y, Vasishta RK, Kakkar N, Dilawari JB, Trehan MS, et al. Non-cirrhotic
portal fibrosis (idiopathic portal hypertension): experience with 151 patients and a review of the
literature. J Gastroenterol Hepatol. 2002 Jan;17(1):6–16.
4. Marra F, Grandaliano G, Valente AJ, Abboud HE. Thrombin stimulates proliferation of liver fatstoring
cells and expression of monocyte chemotactic protein-1: potential role in liver injury.
Hepatol Baltim Md. 1995 Sep;22(3):780–7.
5. Datta DV, Mitra SK, Chhuttani PN, Chakravarti RN. Chronic oral arsenic intoxication as a
137
Indian Journal of Basic and Applied Medical Research; December 2014: Vol.-4, Issue- 1, P. 134-138
135
www.ijbamr.com P ISSN: 2250-284X , E ISSN : 2250-2858
possible aetiological factor in idiopathic portal hypertension (non-cirrhotic portal fibrosis) in India.
Gut. 1979 May;20(5):378–84.
6. Guha Mazumder DN. Chronic arsenic toxicity & human health. Indian J Med Res. 2008
Oct;128(4):436–47.
7. Guha Mazumder DN, Ghose S, Das K, Ghosh A, Ghose KK, Nag S. Immunological studies in
cirrhotic& non-cirrhotic portal fibrosis. Indian J Med Res. 1986 Jul;84:59–61.
8. Nayyar AK, Sharma BK, Sarin SK, Malhotra P, Broor SL, Sachdev G. Characterization of
peripheral blood lymphocytes in patients with non-cirrhotic portal fibrosis: a comparison with
cirrhotics and healthy controls. J Gastroenterol Hepatol. 1990 Oct;5(5):554–9.
9. Yamaguchi N, Tokushige K, Haruta I, Yamauchi K, Hayashi N. Analysis of adhesion molecules in
patients with idiopathic portal hypertension. J Gastroenterol Hepatol. 1999 Apr;14(4):364–9.
10.Dooley JS, Lok A, Burroughs AK, Heathcote J, editors. Sherlock’s diseases of the liver and
biliary system. 12th ed. Chichester, West Sussex ; Hoboken, NJ: Wiley-Blackwell; 2011.
11. Sarin SK, Kapoor D. Non-cirrhotic portal fibrosis: current concepts and management. J
Gastroenterol Hepatol. 2002 May;17(5):526–34.

Thank you for copying data from http://www.arastirmax.com